Cambridge Technologies (Biotechnology) is Biotechnology in United States that focus on quality control standards business. They cover business area such as operator, animal health problem, its USDA-approve autogenous vaccine, strict quality assurance, quality control standard, place, cut-edge molecular diagnostic and manufacturing technique, user, product.
-
Quality Control Standards
-
1525 Bioscience Drive
Worthington, MN 56187
United States
Private
operatoranimal health problemits USDA-approve autogenous vaccinestrict quality assurancequality control standardplacecut-edge molecular diagnostic and manufacturing techniqueuserproduct
* We use standard office opening hours in near Cambridge Technologies (Biotechnology)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cambridge Technologies (Biotechnology) is Biotechnology business from United States that founded in - ( years old in ), Cambridge Technologies (Biotechnology) business is focusing on Quality Control Standards.
Cambridge Technologies (Biotechnology) headquarter office and corporate office address is located in 1525 Bioscience Drive Worthington, MN 56187 United States.
Cambridge Technologies (Biotechnology) was founded in United States.
In , Cambridge Technologies (Biotechnology) is currently focus on quality control standards sector.
Above is snippet of Google Trends for "quality control standards" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cambridge Technologies (Biotechnology), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
